Human antibodies against varicella-zoster virus
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 9, 1996
Issued Date -
N/A
app pub date -
Mar 24, 1994
filing date -
Jul 28, 1993
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention provides human monoclonal antibodies specific for the glycoprotein II subunit of Varicella-zoster virus. Preferred antibodies exhibit strong complement-independent neutralizing activity, antibody dependent cellular cytotoxicity, and cross-reactivity with multiple strains of Varicella-zoster virus.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully